Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
30 November 2020 | Story Nonsidiso Qwabe | Photo Supplied

Acclaimed South African writer, author, and UFS research fellow Zubeida Jaffer was honoured with a lifetime achievement award for her career in journalism during the Standard Bank Sivukile Awards ceremony. 

Passion for journalism spans decades
During the award ceremony on 15 October 2020, Jaffer received the prestigious Allan Kirkland Soga Lifetime Achievement Award, which recognises a sustained and extraordinary contribution to journalism. Jaffer said she never chose journalism, but journalism chose her. She said when she first stepped into a newsroom looking for a holiday job in the 1970s, she did not know she had stepped into her future in news reporting. Since then, Jaffer has earned many accolades in the journalism industry as well as in academia. She also became an acclaimed author, and wrote her third book, Beauty of the Heart: The Life and Times of Charlotte Mannya Maxeke, during her time as a writer-in-residence at the UFS. While at the UFS, she founded the online media platform, The Journalist, a platform that provides history and context for key issues facing South African journalists. This portal also links students with academics across the country and will soon be extended to the African continent and the diaspora.

Jaffer said she felt blessed to be recognised among the many journalism pioneers in South Africa. 

“It’s extremely wonderful because it came so out of the blue. This year, with COVID-19, I was digging deep, and trying my best to keep focus. I’m very thankful. It’s made me pause, reflect, and realise that a lot of things I’ve done have been of value. When living your life, it’s not that you’re aware of that all the time. There are many people doing great things who don’t always get this kind of recognition,” Jaffer said.

Still a great need for journalists in South Africa 

Talking about journalism today, Jaffer said: “I am often overwhelmed to witness the enthusiasm and determination of young journalists across the country who come from humble backgrounds and inspire those around them. Our country is gripped in a bipolar condition. It is not clear how the healing will come, but it will. The challenge is to keep our minds in balance so that we can be strong enough to root out corruption and gender-based violence, while at the same time fully understanding our blessings as a people.”

UFS alumna Rising Star in Journalism 

In another accolade for the UFS, the Upcoming/Rising Star of the Year award went to former UFS Journalism student Brümilda Swartbooi for her article titled ‘Sy het hard vir ons gewerk’. The article highlighted the senseless killing of a woman outside her workplace, minutes after her husband dropped her off.

Brümilda Swartbooi. Photo: Supplied

News Archive

National Department of Health invests R53.5 million in UFS laboratory
2016-02-04

Description: Dr Derek Litthauer Tags: Dr Derek Litthauer

Dr Derek Litthauer
Photo: Supplied

This year has started off on a high note for Dr Derek Litthauer and his team at the South African National Control Laboratory (NCL) for Biological Products. The National Department of Health has awarded the NCL a contract to the value of R53.5 million to continue testing vaccines for the next three years.

Vaccines are biological medicines used to ensure healthy populations by preventing many diseases. The World Health Organization (WHO) estimates that, worldwide, about 5.2 million children under six years old die annually. Of these deaths, 29% are vaccine preventable. Research has revealed that vaccines prevent about 6 million deaths each year globally. Safe and effective vaccines are essential public health tools, which are strictly regulated internationally. It is the NCL’s responsibility to perform quality control testing on all vaccines to be used on humans in South Africa.

This laboratory, the only one of its kind in Africa, receives samples of vaccines from manufacturers and importers for rigorous evaluation and testing. No vaccine may be used in South Africa without a release certificate issued by the Control Lab, certifying that the vaccine is suitable for human use.

The contract is a commitment to ensuring that only vaccines of the highest quality are used in South Africa.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept